Deletions and point mutations in MCL2 and MCL3 patients. (A) Deletions of CDKN2A and TP53 (blue) and mutations of TP53 for comparison (red), according to BM involvement of MCL by morphologic review (yellow). Gray boxes indicate samples not tested. (B) Mutation frequency of 8 selected genes. *BM involvement by morphologic assessment.